Collegium Pharmaceutical Inc (COLL)
37.51
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
37.53
+0.02
(+0.05%)
After-Hours: 20:00
Collegium Pharmaceutical Total Assets (Quarterly): 1.143B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.143B |
| September 30, 2023 | 1.178B |
| June 30, 2023 | 1.214B |
| March 31, 2023 | 1.214B |
| December 31, 2022 | 1.174B |
| September 30, 2022 | 1.201B |
| June 30, 2022 | 1.246B |
| March 31, 2022 | 1.246B |
| December 31, 2021 | 692.08M |
| September 30, 2021 | 741.80M |
| June 30, 2021 | 713.74M |
| March 31, 2021 | 646.06M |
| December 31, 2020 | 643.84M |
| September 30, 2020 | 643.84M |
| June 30, 2020 | 646.87M |
| March 31, 2020 | 634.79M |
| December 31, 2019 | 306.30M |
| September 30, 2019 | 303.98M |
| June 30, 2019 | 301.58M |
| Date | Value |
|---|---|
| March 31, 2019 | 294.36M |
| December 31, 2018 | 291.24M |
| September 30, 2018 | 646.51M |
| June 30, 2018 | 673.33M |
| March 31, 2018 | 696.28M |
| December 31, 2017 | 135.57M |
| September 30, 2017 | 122.67M |
| June 30, 2017 | 124.52M |
| March 31, 2017 | 139.85M |
| December 31, 2016 | 162.02M |
| September 30, 2016 | 98.72M |
| June 30, 2016 | 119.72M |
| March 31, 2016 | 136.34M |
| December 31, 2015 | 97.72M |
| September 30, 2015 | 107.05M |
| June 30, 2015 | 114.17M |
| March 31, 2015 | 47.39M |
| December 31, 2014 | 5.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
301.58M
Minimum
Jun 2019
1.246B
Maximum
Mar 2022
836.36M
Average
713.74M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 470.11M |
| Immunogen Inc (DELISTED) | 822.10M |
| AnaptysBio Inc | 452.39M |
| Recursion Pharmaceuticals Inc | 653.70M |
| Nuvalent Inc | 732.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 947.88M |
| Shareholders Equity (Quarterly) | 195.43M |
| Debt to Equity Ratio | 3.414 |
| Current Ratio | 1.174 |
| Net Debt Paydown Yield | 1.15% |